期刊文献+

ELISA法检测HBsAg灰区和单试剂反应性样本的确认结果分析 被引量:14

Verification Tests for the Samples with Suspected ELISA-Positive HBsAg and One-step Testing
下载PDF
导出
摘要 目的探讨ELISA法检测HBsAg结果判定灰区设置的必要性,以及中和试验对HBsAg灰区和单试剂反应性样本的确认情况。方法采用两个不同厂家生产的ELISA HBsAg试剂对献血者标本分别进行检测,对检测结果在0.7≤S/CO〈1或单试剂为反应性的标本,再用同种试剂进行双孔复试,双孔中至少有1孔结果仍在灰区内或仍为反应性,留取标本做HBsAg中和试验确证。结果 136例灰区标本中HBsAg中和试验检测出阳性标本10例,阳性率为7.35%,结果异常标本14例;159例单试剂反应性标本中HBsAg中和试验检测出阳性标本19例,阳性率为11.95%,结果异常标本16例。灰区与单试剂反应性样本阳性率的差异没有统计学意义;S/CO值在0.70~0.79区间、0.80~0.89区间、0.90~0.99区间的阳性率有逐渐升高的趋势,但差异无显著性;双试剂灰区的阳性率高于单试剂灰区的阳性率,但差异无统计学意义。结论对HBsAg灰区和单试剂反应性标本,ELISA检测漏检率较高,应结合自己实验室实际设置合适的灰区,最大限度地检出这些可疑标本,并进行确认实验,进一步减少HBsAg漏检和误检率,以提高输血安全,同时避免血源的浪费。 Objective To explore the necessity of confirmative detection for the suspected positivity(grey area)in HBsAg ELISA and one-step tests by neutralization test.Methods The blood samples were individually detected by HBsAg ELISA which were provided by two manufacturers.The results in 0.7≤S/CO〈1 or single reactive samples were checked with the same reagent by double-well tests.The samples with one suspected positive well were subjected to HBsAg neutralization for verification.Results Among 136 samples with suspected positive HBsAg,10(7.35%)were confirmed to be positive by HBsAg neutralization test,and 14 were found to be abnormal.Nineteen of 159 samples that showed positive onestep test gave rise to a confirmed positivity by HBsAg neutralization,and 16 were found to be abnormal.The true positive rate was 11.95%.The value of S/COshowed no obvious difference in positive rates between 0.70~0.79,0.80~0.89,and0.90~0.99.Conclusion The false negative rate of ELISA is high in suspected HBsAg(grey area)and one-step tested samples.Verification tests are necessary to reduce the false negative and misdiagnostic frequencies and to ensure the safty of blood transfusion.
出处 《临床输血与检验》 CAS 2015年第3期224-226,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 HBsAg灰区 单试剂反应性 中和试验 HBsAg grey area Single reagent reaction Neutralization test
  • 相关文献

参考文献7

二级参考文献50

  • 1汪恩浩.大规模生产重组酵母乙肝疫苗工艺介绍[J].中国生物制品学杂志,1993,6(4). 被引量:1
  • 2任芙蓉 ,龚晓燕 ,李京京 ,吕秋霜 ,刘长利 ,庄辉 ,SHAN Hua ,王憬惺 .献血员丙型肝炎病毒抗体酶免疫法检测试剂的测量值与其真阳性的相关性[J].中华肝脏病杂志,2005,13(4):255-258. 被引量:38
  • 3田拥军,覃莉,刘慎沛,雷延昌,赵西平,陆蒙吉,杨东亮.8种国产HBsAg试剂盒检测变异HBsAg的效果评价[J].临床检验杂志,2007,25(4):250-253. 被引量:40
  • 4血站技术操作规程,2012.
  • 5Niederhausera C,Taleghani BM,Graziani M,et al.Blood donorscreening:how to decrease the risk of transfusion-transmitted hepa-titis B virusSwiss Med Wkly,2008,138(9-10):134-141.
  • 6Yugi H,Mizui M,Anaka J,et al.Hepatitis B Virus(HBV)screeningstrategy to ensure the safety of blood for transfusion through a combi-nation of immunological testing and nucleic acid amplification testing-Japanese experience.J Clinical Virol2,0063,6(Suppl 1):S56-64.
  • 7Busch MP.Transfusion-transmitted viral infections:building bridgesto transfusion medicine to reduce risks and understand epidemiolo-gy and pathogenesis.Transfusion2,006,46(9):1624-1640.
  • 8Delwart E,Kuhns MC,Busch MP.Surveillance of the genetic varia-tion in incident HIV,HCV,and HBV infections in blood and plas-ma donors:implications for blood safety,diagnosticst,reatment,andmolecular epidemiology.J Med Virol,20067,8(Suppl 1):S30-35.
  • 9Laperche S.Blood safety and nucleic acid testing in Europe.EuroSurveill,2005,10(2):3-4.
  • 10Busch MP,Glynn SA,Stramer SL,et al.A new strategy for estimatingrisks of transfusion-transmitted viral infections based on rates of detec-tion of recently infected donors.Transfusion2,0054,5(2):254-264.

共引文献117

同被引文献124

引证文献14

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部